Medical device maker BD (Becton Dickinson) has withdrawn from talks aimed at resolving a dispute over severance packages for ...

The vascular access catheters market, valued at approximately USD 3.0 billion by the end of 2022, is expected to experience ...

Key Insights The projected fair value for Becton Dickinson is US$330 based on 2 Stage Free Cash Flow to Equity ...

The global soft tissue repair market is on track for substantial growth, with an estimated valuation of USD 6,992.8 million ...

Crossmark Global Holdings Inc. boosted its position in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 1.8% during ...

Becton, Dickinson plans to reduce debt and repurchase $1B in shares. Read why BDX stock is a solid Buy, enhancing financial ...

Axxcess Wealth Management LLC raised its position in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 6.0% in the ...

Stifel Nicolaus analyst Rick Wise maintained a Buy rating on Becton Dickinson (BDX – Research Report) today and set a price target of $280.00. The company’s shares opened today at $226.95. Wise covers ...

Q4 2024 Earnings Call Transcript November 7, 2024 Operator: Hello and welcome to BD’s Fourth Quarter and Full Year Fiscal ...

Becton, Dickinson and Co ( (BDX) ) has released its Q4 earnings. Here is a breakdown of the information Becton, Dickinson and Co presented to ...